Articles by Disease (Diabetes Mellitus)

Modulation of Inducible Nitric Oxide Synthase Activation by Immuno-suppressive Drugs

Journal: Current Drug Metabolism
Volume: 2
Page: 315-329
Author(s): V. Trajkovic

Amylin Replacement With Pramlintide as an Adjunct to Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: A Physiological Approach Toward Improved Metabolic Control

Journal: Current Pharmaceutical Design
Volume: 7
Page: 1353-1373
Author(s): C. Weyer, D. G. Maggs, A. A. Young and O. G. Kolterman

Development of Glucagon-Like Peptide-1-Based Pharmaceuticals as Therapeutic Agents for the Treatment of Diabetes

Journal: Current Pharmaceutical Design
Volume: 7
Page: 1399-1412
Author(s): Daniel J. Drucker

Changes in Immune and Endocrine Systems in Scrapie-Infected Animals

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 1
Page: 171-183
Author(s): X. Ye, A. C. Scallet and R. I. Carp

G Protein-Coupled Receptor Kinase 2 - a Feedback Regulator of Gq Pathway Signalling

Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 1
Page: 139-151
Author(s): J. Theilade, S. Haunso and S. P. Sheikh

The HCMV Chemokine Receptor US28 is a Potential Target in Vascular Disease

Journal: Current Drug Targets - Infectious Disorders
Volume: 1
Page: 151-158
Author(s): D. N. Streblow, S. L. Orloff and J. A. Nelson

Gene Therapy for Diabetes Mellitus

Journal: Current Molecular Medicine
Volume: 1
Page: 325-337
Author(s): T. Yamaoka

Hepatic Cytochrome P450 Regulation in Disease States

Journal: Current Drug Metabolism
Volume: 2
Page: 165-183
Author(s): Po-Yung Cheng and Edward T. Morgan

Ceruloplasmin, the Unique Multi-Copper Oxidase of Vertebrates

Journal: Protein & Peptide Letters
Volume: 8
Page: 159-169
Author(s): Giovanni Musci

Diabetes Mellitus-Cell Transplantation and Gene Therapy Approaches.

Journal: Current Molecular Medicine
Volume: 1
Page: 273-286
Author(s): Tanya Halvorsen and Fred Levine